• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • William Belcher
William Belcher
William Belcher

William Belcher

Partner

  • London UK
Contact Me Today
+44 20 7300 4221
vCard
Email me Call me
Featured award

IFLR 1000 2020

Notable practitioner: Capital markets; Equity, M&A (UK)

Scroll to featured award

Will is an experienced equity capital markets and M&A lawyer.

Will primarily advises listed companies and investment banks on equity capital markets and M&A transactions, and on all regulatory and governance issues affecting listed companies. He has experience across a wide range of sectors, but with an emphasis on advising real estate investment trusts on their IPOs, secondary fundraisings and corporate transactions.

Expertise

Services and Groups

Corporate/M&A & capital markets
Structured real estate
Equity capital markets
M&A

Sectors

Financial institutions & insurance
Life sciences & healthcare
Real estate

CV

Since 2008 Partner, Taylor Wessing
2006 - 2008 Associate, Milbank Tweed Hadley & McCloy
1999 - 2006 Associate, Ashurst
1997 - 1999 Trainee, Ashurst Morris Crisp
1999 Admitted as a lawyer, England & Wales
1997 Guildford Law School
1995 Bachelors, Durham University

Career

Since 2008 Partner, Taylor Wessing
2006 - 2008 Associate, Milbank Tweed Hadley & McCloy
1999 - 2006 Associate, Ashurst
1997 - 1999 Trainee, Ashurst Morris Crisp

Education

1999 Admitted as a lawyer, England & Wales
1997 Guildford Law School
1995 Bachelors, Durham University

Awards

IFLR 1000 2020

Featured

Notable practitioner: Capital markets; Equity, M&A (UK)

Legal 500 UK 2016

Recommended individual - Legal Business

Experience

Hilton Food Group

Hilton Food Group plc on its class 1 acquisition of Icelandic SeaChill, funded by a underwritten placing and senior debt package.

William Belcher
James Homan

Tritax Big Box REIT plc on the GBP370m acquisition of db Symmetry

Tritax Big Box REIT on its acquisition of db Symmetry, which owns one of the UK’s largest strategic land portfolios for the development of Big Box real estate assets and related logistics facilities. The acquisition attributed an enterprise value of GBP370 million to db Symmetry.

Press release
William Belcher
Edward Waldron
Alan Evans
Sarah Bolton
Jane Hilton
Peter Jackson

News Corporation and News Corp UK & Ireland

News Corporation and News Corp UK & Ireland on its recommended cash offer for talkSPORT owner Wireless Group plc for GBP220.3 million.

Louisa Penny
William Belcher

Blackstone

Blackstone on a corporate disposal of an industrial warehouse portfolio.

William Belcher

Intel Capital

Intel Capital on a GBP50 million block trade of shares in Imagination Technologies.

William Belcher

Triple Point Social Housing REIT plc

Triple Point Social Housing REIT plc on its IPO and subsequent C share issue and move to the main market.

William Belcher

William's news & insights

View William's insights
Suspension bridge vanishing point
Click here to find out more
Corporate/M&A & capital markets

Advising Azenta on its US$63 million sale of B Medical Systems

13 January 2026

by William Belcher and Michael Stein

Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising Hilton Foods Limited on its sale of Fairfax Meadow Europe Limited

13 October 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising Coherent on its sale of UK manufacturing site

3 October 2024

by William Belcher and Bryce Bartlett

Click here to find out more
View William's insights

Related news & insights

FinTech Stories
Fintech

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

22 April 2026

by Miroslav Đurić, LL.M.

Click here to find out more
ivdr mdr
Medical devices

Proposed Amendments to the EU Medical Device Regulation

15 April 2026
Briefing

by Bartosz Świdrak

Click here to find out more
biotech helix
Biotech

Impact of the new Biotech Act on Clinical Trials in the EU

15 April 2026
Quick read

by Irina Rebin

Click here to find out more
Life sciences & healthcare

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

15 April 2026
Briefing

by Irina Rebin

Click here to find out more
Road Marking
Corporate/M&A & capital markets

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

14 April 2026

by Paul Thorpe and Jack Coventry

Click here to find out more
Inside the Office Building
Corporate/M&A & capital markets

Advising on Sona's US$45 million Series B funding

8 April 2026

by multiple authors

Click here to find out more
Flag of the European community
Life sciences & healthcare

Life Sciences Legal Lens – Vol. 1

7 April 2026
Click here to find out more

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

1 April 2026

by multiple authors

Click here to find out more
International life sciences
Artificial intelligence

Hungary opens health data infrastructure for AI development

1 April 2026
Briefing

by János Kopasz, AIGP, CIPP/E, CIPM

Click here to find out more
International life sciences
Medical devices

No claim for damages as a result of participation in clinical drug trials

1 April 2026

by Irina Rebin

Click here to find out more
View all insights

Related people

UK
Global
Joshua Gertner

Joshua Gertner

Senior Associate

London
+44 20 7300 7000
Email me
View profile
josef fuss

Josef Fuss

Partner

London
+44 20 7300 4110
Email me
View profile
Collette Bunce

Collette Crocker (née Bunce)

Senior Associate

London
+44 20 7300 7000
Email me
View profile

Ronald Graham

Partner

Dubai
London
+971 43 09 1001
Email me
View profile

Ben Eaves

Associate

London
+44 20 7300 7000
Email me
View profile
Edward Story

Edward Story

Partner

London
+44 20 7300 7147
Email me
View profile
Lorraine Smith

Lorraine Smith

Senior Knowledge Lawyer

London
+44 20 7300 7000
Email me
View profile
Robert Fenner

Robert Fenner

Partner

London
+44 20 7300 4986
Email me
View profile
Ed Chapman

Ed Chapman

Partner

London
+44 20 7300 7014
Email me
View profile
Richard Faichney

Richard Faichney

Partner

London
+44 207 300 4773
Email me
View profile
Full team
Jack Turner

Jack Turner

Associate

London
San Francisco
+44 20 7300 7000
Email me
View profile
Freek Lonzième

Freek Lonzième

Associate

Amsterdam
+31 88 02 43 287
Email me
View profile
Anja Fenge

Dr. Anja Fenge, LL.M.

Partner

Hamburg
+49 40 36803-120
Email me
View profile
Sarah Kelly

Sarah Kelly

Senior Associate

Dublin
+353 1 224 1092
Email me
View profile

Dr. Anne Steinhardt

Salary Partner

Berlin
+49 30 885636 0
Email me
View profile
Peter Hellich

Dr. Peter Hellich

Partner

Munich
San Francisco
+49 89 21038 0
Email me
View profile
Lacy Gratton

Lacy Gratton

Partner

London
+44 207 300 4077
Email me
View profile
Geraerts-Marnix

Marnix Geraerts

Partner

Amsterdam
+31 88 02 43 219
Email me
View profile
jonny bethell

Jonny Bethell

Partner

London
+44 20 7300 7141
Email me
View profile
Kjara Walravens

Kjara Walravens

Associate

Brussels
+32 2 3202 267
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing